2007
DOI: 10.1051/aos:2007021
|View full text |Cite
|
Sign up to set email alerts
|

Les tumeurs brunes des maxillaires

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…ey are encountered in 1% of primary hyperparathyroidism cases [12]. eir radiological aspects include lytic lesions, with well-limited contours, without sclerosis, being either eccentric or cortical, with thinning, blowing, or rupture of the cortex [13]. In most cases, the brown tumors secondary to primary hyperparathyroidism are unique and are most often located in the facial bones, more rarely in the long bones, pelvis, spine, and base of the skull [14].…”
Section: Case Reports In Endocrinologymentioning
confidence: 99%
“…ey are encountered in 1% of primary hyperparathyroidism cases [12]. eir radiological aspects include lytic lesions, with well-limited contours, without sclerosis, being either eccentric or cortical, with thinning, blowing, or rupture of the cortex [13]. In most cases, the brown tumors secondary to primary hyperparathyroidism are unique and are most often located in the facial bones, more rarely in the long bones, pelvis, spine, and base of the skull [14].…”
Section: Case Reports In Endocrinologymentioning
confidence: 99%
“…Brown tumors are osteolytic giant-cell lesions originating from the increased osteoclasts activity in the setting of chronically elevated parathyroid function as both primary and secondary hyperparathyroidism (HPT) ( Triantafillidou et al, 2006 ). Brown tumors involve more frequently the ribs, clavicle, tibia, femur, pelvic girdle and hands ( Elqatni et al, 2011 ), while rarely the maxillo-facial bones (4.5% of cases) ( Slama et al, 2007 ; Lessa et al, 2005 ; Keyser and Postma, 1996 ). It is not easy to distinguish them from osteolytic metastases or lesions from multiple myeloma, with which they share similar characteristics ( Kalathas et al, 2010 ).…”
Section: Introductionmentioning
confidence: 99%